349 related articles for article (PubMed ID: 12224393)
21. Cardiomyopathy is independent of skeletal muscle disease in muscular dystrophy.
Zhu X; Wheeler MT; Hadhazy M; Lam MY; McNally EM
FASEB J; 2002 Jul; 16(9):1096-8. PubMed ID: 12039854
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of sarcoglycans, vinculin-talin-integrin system and filamin2 in alpha- and gamma-sarcoglycanopathy: an immunohistochemical study.
Anastasi G; Cutroneo G; Trimarchi F; Santoro G; Bruschetta D; Bramanti P; Pisani A; Favaloro A
Int J Mol Med; 2004 Dec; 14(6):989-99. PubMed ID: 15547664
[TBL] [Abstract][Full Text] [Related]
23. rAAV vector-mediated sarcogylcan gene transfer in a hamster model for limb girdle muscular dystrophy.
Li J; Dressman D; Tsao YP; Sakamoto A; Hoffman EP; Xiao X
Gene Ther; 1999 Jan; 6(1):74-82. PubMed ID: 10341878
[TBL] [Abstract][Full Text] [Related]
24. Abnormalities of dystrophin, the sarcoglycans, and laminin alpha2 in the muscular dystrophies.
Jones KJ; Kim SS; North KN
J Med Genet; 1998 May; 35(5):379-86. PubMed ID: 9610800
[TBL] [Abstract][Full Text] [Related]
25. Mutations in the delta-sarcoglycan gene are a rare cause of autosomal recessive limb-girdle muscular dystrophy (LGMD2).
Duggan DJ; Manchester D; Stears KP; Mathews DJ; Hart C; Hoffman EP
Neurogenetics; 1997 May; 1(1):49-58. PubMed ID: 10735275
[TBL] [Abstract][Full Text] [Related]
26. Mouse adhalin: primary structure and expression during late stages of muscle differentiation in vitro.
Liu L; Vachon PH; Kuang W; Xu H; Wewer UM; Kylsten P; Engvall E
Biochem Biophys Res Commun; 1997 Jun; 235(1):227-35. PubMed ID: 9196068
[TBL] [Abstract][Full Text] [Related]
27. DNA-fragmentation and expression of apoptosis-related proteins in muscular dystrophies.
Tews DS; Goebel HH
Neuropathol Appl Neurobiol; 1997 Aug; 23(4):331-8. PubMed ID: 9292873
[TBL] [Abstract][Full Text] [Related]
28. Extraocular muscle is spared despite the absence of an intact sarcoglycan complex in gamma- or delta-sarcoglycan-deficient mice.
Porter JD; Merriam AP; Hack AA; Andrade FH; McNally EM
Neuromuscul Disord; 2001 Mar; 11(2):197-207. PubMed ID: 11257478
[TBL] [Abstract][Full Text] [Related]
29. Developmental expression of sarcoglycan gene products in cultured myocytes.
Noguchi S; Wakabayashi E; Imamura M; Yoshida M; Ozawa E
Biochem Biophys Res Commun; 1999 Aug; 262(1):88-93. PubMed ID: 10448073
[TBL] [Abstract][Full Text] [Related]
30. Genetic studies and molecular structures: the dystrophin associated complex.
Beckmann JS
Hum Mol Genet; 1996 Jul; 5(7):865-7. PubMed ID: 8817320
[No Abstract] [Full Text] [Related]
31. [Expression and localization of dystrophin during human skeletal, cardiac and smooth muscle development].
Chevron MP; Demaille J
C R Seances Soc Biol Fil; 1994; 188(5-6):575-84. PubMed ID: 7780798
[TBL] [Abstract][Full Text] [Related]
32. Gene transfer establishes primacy of striated vs. smooth muscle sarcoglycan complex in limb-girdle muscular dystrophy.
Durbeej M; Sawatzki SM; Barresi R; Schmainda KM; Allamand V; Michele DE; Campbell KP
Proc Natl Acad Sci U S A; 2003 Jul; 100(15):8910-5. PubMed ID: 12851463
[TBL] [Abstract][Full Text] [Related]
33. [Dystroglycan linkage and muscular dystrophy].
Shimizu T
Rinsho Shinkeigaku; 2002 Nov; 42(11):1091-4. PubMed ID: 12784674
[TBL] [Abstract][Full Text] [Related]
34. Gamma-sarcoglycan deficiency leads to muscle membrane defects and apoptosis independent of dystrophin.
Hack AA; Ly CT; Jiang F; Clendenin CJ; Sigrist KS; Wollmann RL; McNally EM
J Cell Biol; 1998 Sep; 142(5):1279-87. PubMed ID: 9732288
[TBL] [Abstract][Full Text] [Related]
35. Expression of gamma -sarcoglycan in smooth muscle and its interaction with the smooth muscle sarcoglycan-sarcospan complex.
Barresi R; Moore SA; Stolle CA; Mendell JR; Campbell KP
J Biol Chem; 2000 Dec; 275(49):38554-60. PubMed ID: 10993904
[TBL] [Abstract][Full Text] [Related]
36. Muscle-specific promoters may be necessary for adeno-associated virus-mediated gene transfer in the treatment of muscular dystrophies.
Cordier L; Gao GP; Hack AA; McNally EM; Wilson JM; Chirmule N; Sweeney HL
Hum Gene Ther; 2001 Jan; 12(2):205-15. PubMed ID: 11177557
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of dystroglycan binding to laminin disrupts the PI3K/AKT pathway and survival signaling in muscle cells.
Langenbach KJ; Rando TA
Muscle Nerve; 2002 Nov; 26(5):644-53. PubMed ID: 12402286
[TBL] [Abstract][Full Text] [Related]
38. [Muscular dystrophy due to a mutation in the gene of alpha-sarcoglycan subunit of dystrophin associated protein complex].
Urtasun M; Poza JJ; Gallano P; Lasa A; Sáenz A; Cobo AM; Leturcq F; López de Munain A; García-Bragado F
Med Clin (Barc); 1998 Apr; 110(14):538-42. PubMed ID: 9646269
[TBL] [Abstract][Full Text] [Related]
39. The dystrophin glycoprotein complex: signaling strength and integrity for the sarcolemma.
Lapidos KA; Kakkar R; McNally EM
Circ Res; 2004 Apr; 94(8):1023-31. PubMed ID: 15117830
[TBL] [Abstract][Full Text] [Related]
40. A novel mechanism of myocyte degeneration involving the Ca2+-permeable growth factor-regulated channel.
Iwata Y; Katanosaka Y; Arai Y; Komamura K; Miyatake K; Shigekawa M
J Cell Biol; 2003 Jun; 161(5):957-67. PubMed ID: 12796481
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
